Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2013.08.29
关于变更部分募集资金存放专项账户并签订募集资金三方监管协议的公告
2013.08.29
中国中投证券有限责任公司关于公司变更部分超额募集资金存放专项账户的核查意见
2013.08.29
2013年1-6月财务报告
2013.08.29
第二届董事会第二十六次会议决议公告
2013.08.24
关于股东迁址及更名等的提示性公告
2013.08.13
关于媒体报道的澄清公告
2013.08.02
关于设立全资子公司进展的公告
2013.07.31
2013年半年度业绩快报
2013.07.26
关于股票期权激励计划已授予股票期权注销完成的公告
2013.07.13
关于公司取消股票期权激励计划的会计处理意见
第一页
上一页
125
126
127
128
129
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
